Comments

Zevra Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Zevra Therapeutics (ZVRA) operate in?

Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ZVRANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$7.90

0.111.41%

Pre-Market: 4:24 PM EDT

Q4 2024 Earnings in 11 days from now on Tue Mar 11th, after the market close

Zevra Therapeutics (ZVRA) Forecast

News Earnings Zevra Therapeutics (ZVRA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Zevra Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ZVRA | Benzinga

Explore Zevra Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ZVRA.

Open	-
Close	-
Volume / Avg.	15.00 / 425.84K
Day Range	- - -
52 Wk Range	4.20 - 9.76
Market Cap	$421.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	10.86%
Days to Cover	17.3

Recent News

Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of Neimann-Pick disease, type C. This approval follows favorable voting by the Genetic Metabolic Diseases Advisory Committee.

Vandana Singh

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Zevra Therapeutics Mixed Q2 Results: Details

Zevra Therapeutics reported its second-quarter financial results Tuesday. Here's a look at the details.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	15.00 / 425.84K
Day Range	- - -
52 Wk Range	4.20 - 9.76
Market Cap	$421.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	10.86%
Days to Cover	17.3

About Zevra Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to creat...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Zevra Therapeutics (ZVRA) stock?

You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.

View our list of the best stock brokerages

Who are Zevra Therapeutics (ZVRA) competitors?

Other companies in Zevra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the forecast, or price target, for Zevra Therapeutics (ZVRA) stock?

Zevra Therapeutics has a consensus price target of $21.00.

What is the current price for Zevra Therapeutics (ZVRA)?

The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $7.9 last updated February 27, 2025 at 4:24 PM EST.

Does Zevra Therapeutics (ZVRA) pay a dividend?

There are no upcoming dividends for Zevra Therapeutics.

When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?

Zevra Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Zevra Therapeutics (ZVRA) going to split?

There is no upcoming split for Zevra Therapeutics.

What sector and industry does Zevra Therapeutics (ZVRA) operate in?

Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.